Skip to main content
. Author manuscript; available in PMC: 2010 Sep 2.
Published in final edited form as: Methods. 2000 Jan;20(1):4–17. doi: 10.1006/meth.1999.0901

TABLE 4.

Evaluation of the Methods with Experimental Data

Description of the Experiments
m = Number of Mutations per Culture
Exp Mutant Cultures Jackpots Zeros Mean Median Method 1 2 3 4 5 7 8
phenotype LD LC Drake Jones LC, MSS,
p0 mean median median median ML ML
1 Lac+ 60 2 49 24 0 m 0.20 4.38 0.29 1.00 UD UD 0.20
−95%CL 0.10 NA 0.11
+95%CL 0.36 NA 0.31
2 Lac+ 52 0 11 1.9 1 m 1.55 0.57 0.89 1.77 0.84 0.87 1.11
−95%CL 1.06 0.89 0.77
+95%CL 2.20 1.32 1.49
3 RifR 20 2 1 12.6 5.5 m 3.00 3.06 2.54 4.00 2.32 2.9 2.9
−95%CL 1.40 1.70 1.90
+95%CL 6.67 4.94 4.10
4 RifR 16 1 0 100 37.5 m NA 17.7 10.4 14.2 9.2 11.2 11.0
−95%CL 7.6 8.1
+95%CL 17.0 14.2
5 Lac+ 30 1 13 2 1 m 0.84 0.67 0.89 1.77 0.84 0.44 0.71
−95%CL 0.47 0.29 0.39
+95%CL 1.37 0.89 1.09
6 Lac+ 30 3 6 15.3 1.5 m 1.61 3.32 1.14 2.08 1.04 1.04 1.23
−95%CL 0.96 0.89 0.76
+95%CL 2.56 1.69 1.77
5&6 Lac+ 60 4 19 8.6 1 m 1.15 1.84 0.89 1.77 0.84 0.72 0.95
−95%CL 0.80 0.89 0.67
+95%CL 1.59 1.32 1.27

UD = undefined; NA = not applicable; CL = Confidence limits. Lac+ = the ability to utilize lactose; RilR = resistance to rifampicin.